Vickie L. Capps's most recent trade in Amedisys Inc. was a trade of 9,818 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | Vickie L. Capps | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 9,818 | 0 (0%) | 0% | - | Common Stock | |
| Orthofix Medical Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 18,841 | 21,934 (0%) | 0% | 0 | Common Stock | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,667 | 11,667 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,750 | 74,098 | - | 0 | Common Stock | |
| Amedisys Inc. | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2025 | 1,690 | 9,818 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 35,270 | 35,270 | - | - | Employee Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 3,093 | 3,093 (0%) | 0% | 0 | Common Stock | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 2,305 | 70,348 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 68,043 | - | 0 | Common Stock | |
| Amedisys Inc. | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,678 | 8,128 (0%) | 0% | 0 | Common Stock | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Other type of transaction at price $ 0.00 per share. | 29 Feb 2024 | 1,493 | 65,543 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Amedisys Inc. | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,941 | 6,450 (0%) | 0% | 0 | Common Stock | |
| Janux Therapeutics Inc | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Amedisys Inc. | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 1,304 | 4,509 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Vickie L. Capps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 574 | 3,205 (0%) | 0% | 0 | Common Stock |